HuGE Literature Finder
Records
1
-
30
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population. The Korean journal of internal medicine 2020 May 35 (3): 672-681. Reza Hasan Al, Anamika Wardatul Jannat, Chowdhury Md Miraj Kobad, Mostafa Mohammad Golam, Uddin M Aft |
| The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients. Frontiers in oncology 2020 10 726. Liu Shaokun, Huang Tanxiao, Liu Ming, He Wenlong, Zhao YingShen, Yang Lizhen, Long Yingjiao, Zong Dandan, Zeng Huihui, Liu Yuanyuan, Liao Wenting, Duan Jingxian, Gong Subo, Chen Shi |
| Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis. Pathology, research and practice 2019 Jul 152538. Luan Lan, Wang Hongying, Zhao Beibei, Wang Fan, Shi Juan, Xu Xiaj |
| The MDM2 rs937283 A > G variant significantly increases the risk of lung and gastric cancer in Chinese population. International journal of clinical oncology 2018 May . Chen Bifeng, Wang Jieling, Chen Yucan, Gu Xiuli, Feng Xianho |
| Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer. Oncotarget 2018 Jan 9 (3): 3214-3229. Stumbryte Ausra, Gudleviciene Zivile, Kundrotas Gabrielis, Dabkeviciene Daiva, Kunickaite Agne, Cicenas Sauli |
| Association of p73 gene G4C14-A4T14 polymorphism and MDM2 gene SNP309 with non-small cell lung cancer risk in a Chinese population. Oncology letters 2017 Aug 14 (2): 1817-1822. Li Wen, Wang Shuang Shuang, Deng Jing, Tang Jian X |
| Oral mucosa and lung cancer: Are genetic changes in the oral epithelium associated with lung cancer? Nigerian journal of clinical practice 2017 Jan 20 (1): 12-18. Kömerik N, Yüce E, Calapo?lu N S, Ko?ar P A, Çakir M, Koparan |
| MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients. Journal of Cancer 2017 8 (12): 2154-2162. Deben Christophe, Op de Beeck Ken, Van den Bossche Jolien, Jacobs Julie, Lardon Filip, Wouters An, Peeters Marc, Van Camp Guy, Rolfo Christian, Deschoolmeester Vanessa, Pauwels Patri |
| The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls. Panminerva medica 2016 Dec 58 (4): 341-348. Tian Xiaodong, Wang Bo, Guo Juntang, Liu Xi, Zhang Tao, Liang Chaoyang, Zhou Naikang, Hou Xiaobin, Ma Yongfu, Yu Hua, Chen Lei, Ren Zhipeng, Fan Kaijie, Tian Qi |
| Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Sep 11 (9): 1493-502. Schrock Alexa B, Frampton Garrett M, Suh James, Chalmers Zachary R, Rosenzweig Mark, Erlich Rachel L, Halmos Balazs, Goldman Jonathan, Forde Patrick, Leuenberger Kurt, Peled Nir, Kalemkerian Gregory P, Ross Jeffrey S, Stephens Philip J, Miller Vincent A, Ali Siraj M, Ou Sai-Hong Ignati |
| Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma. Cancer medicine 2016 May . Enokida Yasuaki, Shimizu Kimihiro, Atsumi Jun, Kakegawa Seiichi, Takase Yoshiaki, Kaira Kyoichi, Yashima Hideaki, Araki Takuya, Nakazawa Seshiru, Ohtaki Yoichi, Nagashima Toshiteru, Alexander Lezhava, Usui Kengo, Ishikawa Toshihisa, Hayashizaki Yoshihide, Takeyoshi Izu |
| Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC. Clinical lung cancer 2015 Sep 16 (5): e37-53. Qian Ji, Liu Hongliang, Gu Shaohua, Wu Qihan, Zhao Xueying, Wu Wenting, Wang Haijian, Wang Jiucun, Chen Hongyan, Zhang Wei, Wei Qingyi, Jin Li, Lu Da |
| Association of p53 and mdm2 in the development and progression of non-small cell lung cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jul 36 (7): 5425-32. Javid Jamsheed, Mir Rashid, Julka P K, Ray P C, Saxena Alpa |
| Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon. International journal of cancer. Journal international du cancer 2015 Jul 137 (1): 96-103. Gansmo Liv B, Knappskog Stian, Romundstad Pål, Hveem Kristian, Vatten Lars, Lønning Per |
| Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients. British journal of cancer 2015 Mar 112 (6): 1114-20. Zajkowicz A, Butkiewicz D, Drosik A, Giglok M, Suwi?ski R, Rusin |
| Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population. Thoracic cancer 2015 Jan 6 (1): 91-6. Wang Xu, Jin Lina, Cui Jiuwei, Ma Kewei, Chen Xiao, Li W |
| MDM2 (RS769412) G>A Polymorphism in Cigarette Smokers: a Clue for the Susceptibility to Smoking and Lung Cancer Risk. Asian Pacific journal of cancer prevention : APJCP 2015 16 (9): 4057-60. Ahmad Dilshad, Bakairy Abdul Karieem, Katheri Abdull Malika, Tamimi Wale |
| Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk. Biomedical reports 2014 Sep 2 (5): 719-724. Enokida Yasuaki, Shimizu Kimihiro, Kakegawa Seiichi, Atsumi Jun, Takase Yoshiaki, Miyamae Yohei, Nagashima Toshiteru, Ohtaki Yoichi, Kaira Kyoichi, Sunaga Noriaki, Yanagitani Noriko, Yoshino Reiko, Tsunekawa Katsuhiko, Igai Hitoshi, Kamiyoshihara Mitsuhiro, Usui Kengo, Lezhava Alexander, Tomizawa Yoshio, Ishikawa Toshihisa, Murakami Masami, Hayashizaki Yoshihide, Takeyoshi Izu |
| Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis. Genetic testing and molecular biomarkers 2014 May 18 (5): 357-65. Kong Qian, Li Ping, Tian Qiong, Ha Min-W |
| MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients. Oncology research and treatment 2014 37 (4): 176-80. Wang Xu, Wang Yi-Zhuo, Ma Ke-Wei, Chen Xiao, Li W |
| Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer. Cancer biology & therapy 2014 15 (11): 1542-51. Zheng Datong, Chen Yanping, Gao Caijie, Wei Yongyue, Cao Guochun, Lu Nan, Hou Yayi, Jiang Xiuqin, Wang Jianj |
| Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. International journal of radiation oncology, biology, physics 2013 Jan 85 (1): 251-7. Tucker Susan L, Li Minghuan, Xu Ting, Gomez Daniel, Yuan Xianglin, Yu Jinming, Liu Zhensheng, Yin Ming, Guan Xiaoxiang, Wang Li-E, Wei Qingyi, Mohan Radhe, Vinogradskiy Yevgeniy, Martel Mary, Liao Zhongxi |
| P53 Arg72Pro and MDM2 SNP309 polymorphisms cooperate to increase lung adenocarcinoma risk in Chinese female non-smokers: a case control study. Asian Pacific journal of cancer prevention : APJCP 2013 14 (9): 5415-20. Ren Yang-Wu, Yin Zhi-Hua, Wan Yan, Guan Peng, Wu Wei, Li Xue-Lian, Zhou Bao-S |
| SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women. PloS one 2013 8 (9): e73794. Okano Yasuko, Nezu Uru, Enokida Yasuaki, Lee Ming Ta Michael, Kinoshita Hiroko, Lezhava Alexander, Hayashizaki Yoshihide, Morita Satoshi, Taguri Masataka, Ichikawa Yasushi, Kaneko Takeshi, Natsumeda Yutaka, Yokose Tomoyuki, Nakayama Haruhiko, Miyagi Yohei, Ishikawa Toshihi |
| MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. International journal of cancer. Journal international du cancer 2012 Dec 131 (11): 2710-6. Ryan Bríd M, Calhoun Kara M, Pine Sharon R, Bowman Elise D, Robles Ana I, Ambs Stefan, Harris Curtis |
| MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN. Experimental and therapeutic medicine 2012 Oct 4 (4): 569-576. He Wenwu, Long Jianxiong, Xian Lei, Pang Feng, Su Li, Wei Shixiu, Wei Bo, Hu Yanli |
| Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls. PloS one 2012 7 (7): e41546. Zhuo Wenlei, Zhang Liang, Zhu Bo, Ling Junjun, Chen Zhengta |
| Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011 Nov 6 (11): 1793-800. Liu Li, Wu Chen, Wang Ying, Zhong Rong, Duan Shengyu, Wei Sheng, Lin Songyi, Zhang Xinyu, Tan Wen, Yu Dianke, Nie Shaofa, Miao Xiaoping, Lin Dongx |
| Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk. In vivo (Athens, Greece) 0 34 (3): 1047-1052. Lin Yu-Chao, Chang Wen-Shin, Shen Te-Chun, Li Hsin-Ting, Li Chia-Hsiang, Hsiau Yu-Chen, Wang Yun-Chi, Wu Cheng-Nan, Gong Chi-Li, Wang Zhi-Hong, Tsai Chia-Wen, Hsia Te-Chun, Bau DA-Ti |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: